Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 19 | 2024 | 2159 | 5.040 |
Why?
|
| Hydroxychloroquine | 11 | 2024 | 427 | 4.490 |
Why?
|
| Antirheumatic Agents | 8 | 2024 | 1374 | 2.070 |
Why?
|
| Lupus Nephritis | 4 | 2022 | 318 | 1.660 |
Why?
|
| Retinal Diseases | 5 | 2024 | 702 | 1.270 |
Why?
|
| Ophthalmology | 2 | 2022 | 549 | 0.920 |
Why?
|
| Kidney Failure, Chronic | 3 | 2022 | 2471 | 0.880 |
Why?
|
| Scavenger Receptors, Class F | 1 | 2022 | 16 | 0.800 |
Why?
|
| Syphilis | 1 | 2024 | 241 | 0.770 |
Why?
|
| Rheumatic Diseases | 4 | 2021 | 639 | 0.710 |
Why?
|
| Hospitalization | 6 | 2024 | 10790 | 0.660 |
Why?
|
| Exanthema | 1 | 2024 | 504 | 0.660 |
Why?
|
| Arthritis | 1 | 2024 | 666 | 0.640 |
Why?
|
| Career Mobility | 1 | 2020 | 258 | 0.620 |
Why?
|
| Immunomodulation | 1 | 2022 | 547 | 0.600 |
Why?
|
| Kidney Transplantation | 3 | 2022 | 4215 | 0.570 |
Why?
|
| Eye Diseases | 1 | 2022 | 651 | 0.560 |
Why?
|
| Phagocytosis | 1 | 2022 | 1535 | 0.520 |
Why?
|
| Physicians, Women | 1 | 2020 | 495 | 0.480 |
Why?
|
| Cholelithiasis | 1 | 2015 | 408 | 0.440 |
Why?
|
| Autoantibodies | 1 | 2022 | 2118 | 0.430 |
Why?
|
| Myocardial Infarction | 3 | 2022 | 11891 | 0.420 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2022 | 3763 | 0.400 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1192 | 0.400 |
Why?
|
| British Columbia | 2 | 2022 | 240 | 0.390 |
Why?
|
| Cause of Death | 2 | 2019 | 3725 | 0.380 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 4166 | 0.360 |
Why?
|
| Venous Thromboembolism | 2 | 2022 | 1864 | 0.350 |
Why?
|
| Patient Readmission | 1 | 2022 | 3323 | 0.310 |
Why?
|
| Databases, Factual | 7 | 2021 | 8035 | 0.300 |
Why?
|
| Drug Dosage Calculations | 2 | 2018 | 118 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 3 | 2022 | 7475 | 0.290 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3334 | 0.270 |
Why?
|
| Case-Control Studies | 5 | 2024 | 22053 | 0.260 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 2250 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2024 | 10827 | 0.250 |
Why?
|
| Rheumatology | 2 | 2023 | 611 | 0.250 |
Why?
|
| Middle Aged | 19 | 2024 | 220352 | 0.250 |
Why?
|
| Humans | 37 | 2024 | 760621 | 0.220 |
Why?
|
| Abducens Nerve Diseases | 1 | 2024 | 44 | 0.220 |
Why?
|
| Dyskinesias | 1 | 2023 | 79 | 0.210 |
Why?
|
| Aged | 15 | 2024 | 169152 | 0.210 |
Why?
|
| Cohort Studies | 9 | 2024 | 41335 | 0.200 |
Why?
|
| Azathioprine | 1 | 2023 | 356 | 0.200 |
Why?
|
| Gout | 2 | 2020 | 620 | 0.200 |
Why?
|
| Female | 23 | 2024 | 391270 | 0.190 |
Why?
|
| Confusion | 1 | 2023 | 279 | 0.190 |
Why?
|
| Male | 19 | 2024 | 359744 | 0.190 |
Why?
|
| STAT Transcription Factors | 1 | 2022 | 188 | 0.190 |
Why?
|
| Proportional Hazards Models | 4 | 2022 | 12531 | 0.190 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 2942 | 0.180 |
Why?
|
| Cardiovascular Diseases | 4 | 2019 | 15757 | 0.180 |
Why?
|
| Risk | 2 | 2023 | 9631 | 0.180 |
Why?
|
| Stroke | 1 | 2022 | 9962 | 0.180 |
Why?
|
| Phagocytes | 1 | 2022 | 296 | 0.170 |
Why?
|
| California | 1 | 2024 | 1416 | 0.170 |
Why?
|
| Albumins | 1 | 2022 | 575 | 0.170 |
Why?
|
| Colchicine | 1 | 2021 | 261 | 0.170 |
Why?
|
| Current Procedural Terminology | 1 | 2019 | 90 | 0.160 |
Why?
|
| Adult | 12 | 2024 | 219994 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2022 | 360 | 0.160 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 2061 | 0.150 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2021 | 225 | 0.150 |
Why?
|
| Medicare | 4 | 2022 | 6786 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 1246 | 0.140 |
Why?
|
| Depression | 1 | 2016 | 8044 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2022 | 1871 | 0.140 |
Why?
|
| Methotrexate | 1 | 2023 | 1719 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 6659 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 1 | 2022 | 901 | 0.130 |
Why?
|
| United States | 8 | 2023 | 72461 | 0.130 |
Why?
|
| Logistic Models | 3 | 2020 | 13314 | 0.130 |
Why?
|
| Algorithms | 3 | 2022 | 13981 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 1791 | 0.120 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 867 | 0.120 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 1047 | 0.120 |
Why?
|
| Risk Factors | 5 | 2024 | 74359 | 0.120 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2326 | 0.120 |
Why?
|
| Osteoarthritis | 1 | 2022 | 1055 | 0.120 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 894 | 0.110 |
Why?
|
| Waiting Lists | 1 | 2019 | 763 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4775 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2015 | 231 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2021 | 9716 | 0.100 |
Why?
|
| Leadership | 1 | 2020 | 1371 | 0.090 |
Why?
|
| Comorbidity | 2 | 2022 | 10551 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2022 | 8313 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2023 | 65017 | 0.090 |
Why?
|
| Natural Language Processing | 1 | 2019 | 1135 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 4541 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 9530 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 12965 | 0.080 |
Why?
|
| Postpartum Period | 1 | 2015 | 1167 | 0.080 |
Why?
|
| Body Weight | 1 | 2018 | 4611 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3164 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12159 | 0.070 |
Why?
|
| Sex Factors | 1 | 2020 | 10547 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2019 | 10182 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9411 | 0.060 |
Why?
|
| Sepsis | 1 | 2019 | 2592 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2019 | 5990 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14660 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2021 | 24123 | 0.050 |
Why?
|
| Incidence | 1 | 2021 | 21392 | 0.050 |
Why?
|
| Young Adult | 2 | 2022 | 58741 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18137 | 0.050 |
Why?
|
| Registries | 1 | 2019 | 8469 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15840 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2018 | 12914 | 0.040 |
Why?
|
| Multi-Institutional Systems | 1 | 2019 | 43 | 0.040 |
Why?
|
| Pleurisy | 1 | 2019 | 54 | 0.040 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 2622 | 0.040 |
Why?
|
| Disease Progression | 1 | 2016 | 13502 | 0.040 |
Why?
|
| Time Factors | 1 | 2021 | 40165 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25942 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 281 | 0.040 |
Why?
|
| Electronics | 1 | 2020 | 315 | 0.040 |
Why?
|
| Gout Suppressants | 1 | 2020 | 177 | 0.040 |
Why?
|
| Clinical Coding | 1 | 2019 | 181 | 0.040 |
Why?
|
| Osteonecrosis | 1 | 2019 | 229 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 29658 | 0.040 |
Why?
|
| Hospital Information Systems | 1 | 2019 | 394 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 2019 | 342 | 0.030 |
Why?
|
| Drugs, Generic | 1 | 2021 | 448 | 0.030 |
Why?
|
| Mice | 1 | 2022 | 81208 | 0.030 |
Why?
|
| Goals | 1 | 2020 | 708 | 0.030 |
Why?
|
| Uric Acid | 1 | 2020 | 806 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2023 | 2145 | 0.030 |
Why?
|
| Drug Approval | 1 | 2021 | 816 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2022 | 1486 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2023 | 1824 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 29749 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1677 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 54303 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 80372 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 167963 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1941 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8803 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3736 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2283 | 0.020 |
Why?
|
| Medicaid | 1 | 2021 | 2815 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8555 | 0.020 |
Why?
|
| Mortality | 1 | 2018 | 2916 | 0.020 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_